In vitro bioactivity and gene expression by cells cultured on titanium dioxide doped phosphate-based glasses
Source abstract
Abstract
In our previous study, glasses with 50 P(2)O(5)-(20-15) Na(2)O-30 CaO-(0-5 mol%) TiO(2) have been prepared by the conventional melt-quenching process. MG63 cell proliferation, gene expression, in vivo biocompatibility, and bioactivity of these glasses is the concern of this study. The results showed that addition of TiO(2) in small amounts up to 5 mol% enhanced the biocompatibility of these glasses. The cell metabolic activity was conspicuous, on 3 and 5 mol% TiO(2) compositions in particular, with no significant difference from Thermanox control over a period of 21 days. The findings from the gene expression study showed that, at day 1 and on 5 mol% TiO(2) glass, core binding protein factor alpha 1 (Cbfa1) and alkaline phosphatase (ALP) showed significantly lower transcription level; however, collagen type I alpha subunit I (COLIAI) and Osteonectin (Sparc) showed no significant differences compared to the control. At day 7, all these genes transcription levels were not significantly different form the control, but at day 14, they were significantly higher than the control. Moreover, there were no significant differences detected in these genes on both 3 and 5 mol% TiO(2) glasses up to 7 days. At day 14; however, 5 mol% TiO(2) glasses showed significantly higher level than 3 mol% TiO(2) composition. This was also correlated by the presence of new bone tissue at the bone-particles interface for 5 mol% TiO(2) composition after 5 weeks of implantation in rat calvarium. Regardless of this favourable cell response and gene up-regulation, these glasses showed no evidence of apatite layer formation after 14 days incubation in SBF.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Collagen: Extraction and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Bone tissue engineering: hope vs hype10.1006/bbrc.2002.6519 ↗
2. Bioactive glasses
3. Bioactive metals: preparation and properties
4. Flow cytometry analysis of the effects of pre-immersion on the biocompatibility of glass reinforced hydroxyapatite plasma-sprayed coatings10.1016/S0142-9612(99)00249-5 ↗
5. Bioactivity of gel-glass powders in the CaO-SiO2-system: a comparison with ternary (CaO-P2O5-SiO2) and quaternary glasses (SiO2-CaO-P2O5-Na2O)10.1002/jbm.a.10532 ↗
6. Osteoblast attachment and mineralized nodule formation on rough and smooth 45S5 bioactive glass monoliths10.1002/jbm.a.20075 ↗
7. Effect of particulate bioactive glasses on human macrophages and monocytes in vitro10.1002/jbm.a.30262 ↗
8. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function10.1016/S0142-9612(99)00181-7 ↗
9. Compositional dependence of the formation of calcium phosphate film on bioglass10.1002/jbm.820140107 ↗
10. Auger spectroscopy analysis of bioglass corrosion films10.1111/j.1151-2916.1976.tb09382.x ↗
11. Development of soluble glasses for biomedical use. Part 2: the biological response of human osteoblast cell lines to phosphate-based soluble glasses
12. High concentrations of bioactive glass material (BioGran®) vs. autogenous bone for sinus floor elevation10.1034/j.1600-0501.2002.130412.x ↗
13. Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range10.1034/j.1600-0501.2000.011004334.x ↗
14. Processing, characterisation and biocompatibility of iron-phosphate glass fibres for tissue engineering10.1016/j.biomaterials.2003.10.013 ↗
15. Soluble phosphate glasses: in vitro studies using human cells of hard and soft tissue origin10.1016/j.biomaterials.2003.08.054 ↗
16. Soluble phosphate glass fibres for bone-ligament interface
17. Craniofacial muscle engineering using a 3-dimensional glass fibre constructs10.1016/j.biomaterials.2004.04.049 ↗
18. Osteoblast responses to tap-cast and sintered bioactive glass ceramics10.1002/jbm.a.30024 ↗
19. Pre-mineralisation of starch/polycaprolactone bone tissue engineering scaffolds by a calcium-silicate-based process
20. Abou Neel EA, Knowles JC. Physical and biocompatibility studies of novel titanium dioxide doped phosphate-based glasses for bone tissue engineering applications. 2007; under review.10.1007/s10856-007-3079-5 ↗
21. Calcium phosphates and glass composite coatings on zirconia for enhanced biocompatibility10.1016/j.biomaterials.2003.10.094 ↗
22. Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold10.1016/j.biomaterials.2003.07.001 ↗
23. Long-term craniofacial osteoblast culture on a sodium phosphate and a calcium/sodium phosphate glass10.1002/jbm.a.10574 ↗
24. Bone oranotypic culture method. A model for cytocompatibility testing of biomaterials
25. The in vitro response of osteoblasts to bioactive glass10.1016/0142-9612(87)90115-3 ↗
26. Evaluation of the osteoblast response to a silica gel in vitro
27. Poly (d,l-lactic acid) coated 45S5 Bioglass®-based scaffolds: processing and characterization10.1002/jbm.a.30636 ↗
28. Properties of sodium-based ternary phosphate glasses produced from readily available phosphate salts10.1016/j.jnoncrysol.2006.08.043 ↗
29. Characterisation of antimicrobial copper releasing degradable phosphate glass fibres10.1016/j.biomaterials.2004.07.024 ↗
30. The modulation of tissue-specific gene expression in rat nasal chondrocyte culture by bioactive glasses10.1016/j.biomaterials.2004.01.016 ↗
31. In vitro evaluation of novel bioactive composites based on Bioglass®-filled polylactide foams for bone tissue engineering scaffolds10.1002/jbm.a.20055 ↗
32. Response of MG63 osteoblast-like cells onto polycarbonate membrane surfaces with different micropore sizes10.1016/j.biomaterials.2003.11.034 ↗
33. Effect of calmidazolium on Ca2+ movement and proliferation in human osteosarcoma cells10.1111/j.1440-1681.2004.04087.x ↗
34. Osteogenic potential of human-periosteum derived progenitor cells in PLGA scaffold using allogenic serum10.1631/jzus.2006.B0817 ↗
35. Collagens—structure, function, and biosynthesis10.1016/j.addr.2003.08.002 ↗
36. Dose-and time-dependant effect of bioactive gel-glass ionic dissolution products on human fetal osteoblast-specific gene expression10.1002/jbm.b.30249 ↗
37. Biomaterials and bone mechanotransduction10.1016/S0142-9612(01)00002-3 ↗
38. Bone repair in the twenty-first century: biology, chemistry or engineering?10.1098/rsta.2004.1466 ↗
39. Sparc inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-β signalling system10.1091/mbc.e03-01-0001 ↗
40. Genetic basis for the evolution of vertebrate mineralized tissue10.1073/pnas.0404279101 ↗
41. Dynamic expression of Sparc precedes formation of skeletal elements in the Medeka (Oryzias latipes)10.1016/j.gene.2006.01.011 ↗
42. Behaviour of moderately differentiated osteoblast-like cells cultured in contact with bioactive glasses10.22203/eCM.v004a05 ↗
43. Detection of novel skeletogenesis target genes by comprehensive analysis of a Runx 2−1− mouse model10.1016/j.modgep.2006.05.014 ↗
44. Different roles of Runx2 during early neural crest-derived bone and tooth development10.1359/jbmr.060413 ↗
45. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia10.1016/S0092-8674(00)80260-3 ↗
46. Phosphate provides Runx2/Cbfa1 in bone cells10.1006/bbrc.2000.4108 ↗
47. Effect of iron on the surface, degradation and ion release properties of phosphate-based glass fibres10.1016/j.actbio.2005.05.001 ↗